{"version":"1.0","type":"link","title":"Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer.","author_name":"Gee JM 외","author_url":"https://prs-insight.online/author/Gee%20JM","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/41473","thumbnail_width":1200,"thumbnail_height":630}